Immunotherapy Technology & IP Landscape Dashboard

Immunotherapy Technology & IP Landscape Dashboard

299.00 every month 499.00 every month

UPDATED MONTHLY

Immunotherapy landscape overview

Immunotherapy is the treatment of diseases by activating or suppressing body's natural immune system. Cancer immunotherapy, also known as immuno-oncology, is the mostly common immunotherapy that modulates body’s own immune system to prevent, target, attack, and eliminate cancer.

Several types of immunotherapy have been widely adopted, which include monoclonal antibodies (mabs), oncolytic virus therapy, cancer vaccines, immunomodulators, adoptive cell transfer and checkpoint inhibitors. Leading targeted genes include PD-1, CD19, PD-L1, HER2, IDO, CD40, STAT3, CTLA-4, GD2, CD20, EGFT, TLR7 and IFNAR1.

Major players covered in this landscape

AbbVie, Adaptimmune, Amgen, AstraZeneca, Aurora Biopharma, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis, Pfizer and Roche.

sale
Subscribe

Gain and share insights visually and intuitively with the Intellar® landscape experience

INT_Intellar_v5_competitive-intelligence-dashboard-screenshots-1500.gif
 

Other available Life Sciences landscapes

 

The growing Intellar Library